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Abstract
Introduction: Joubert syndrome is a rare congenital disorder characterized by brain malformation, developmental
delay with hypotonia, ocular motor apraxia, and breathing abnormalities. Joubert syndrome is a genetically highly
heterogeneous ciliopathy disorder with 23 identified causative genes. The diagnosis is based on brain imaging
showing the “molar tooth sign” with cerebellar vermis agenesis. We describe a consanguineous Moroccan family
with three affected siblings (18-year-old boy, 13-year-old girl, and 10-year-old boy) showing typical signs of Joubert
syndrome, and attempt to identify the underlying genetic defect in this family.
Methods: We performed genome-wide homozygosity mapping using a high-resolution array followed by targeted
Sanger sequencing to identify the causative gene.
Results: This approach found three homozygous regions, one including the AHI1 gene. Direct sequencing of the 26
coding exons of AHI1 revealed a homozygous mutation (p.Thr304AsnfsX6) located in exon 7 present in the three
Joubert syndrome-affected Moroccan siblings. Of more interest, this truncating mutation was previously reported in
patients with compound heterozygous Joubert syndrome originating from Spain (one patient) and from the
Netherlands (two patients), suggesting a possible founder effect or mutational hotspot.
Conclusions: Combined homozygosity mapping and targeted sequencing allowed the rapid detection of the
disease-causing mutation in the AHI1 gene in this family affected with a highly genetically heterogeneous disorder.
Carriers of the same truncating mutation (p.Thr304AsnfsX6), originating from Spain and the Netherlands, presented
variable clinical characteristics, thereby corroborating the extreme heterogeneity of Joubert syndrome.
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Introduction
Joubert syndrome (JBTS; Mendelian Inheritance in Man,
MIM #213300) is a rare congenital disorder characterized
by a distinctive brain malformation, developmental delay
with hypotonia, ocular motor apraxia, and breathing ab-
normalities [1]. The diagnosis is based on a characteristic
feature of brain imaging, the “molar tooth sign” (MTS)
reflecting agenesis of the cerebellar vermis, and brainstem
alterations. The MTS has also been described in many
syndromes included in the designation “Joubert syndrome
and related disorders” (JSRDs) with involvement of several
other organs including the eye, kidney, and liver [2–4].
JBTS is a genetically heterogeneous disorder. Thus far, 23
genes have been identified of which 22 are autosomal
recessive and one is X-linked recessive.
Most genes causing JBTS encode proteins involved in
primary cilia functions, thus JBTS is included in a group
of disorders called ciliopathies. Mutations in several
genes implicated in JBTS have been identified in other
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ciliopathies such as MORM syndrome (mental retard-
ation, truncal obesity, retinal dystrophy, and micropenis;
MIM #610156) [5] and nephronophthisis (NPHP; MIM
#256100), Meckel syndrome (MIM #249000) [6, 7],
and oral-facial-digital syndrome type 1 (OFD1; MIM
#311200) or type 6 (MIM #277170), thus suggesting
that various clinically distinct ciliopathies may be allelic.
The considerable phenotypic overlap and wide variability
of these ciliopathies can be explained by their common
molecular and cellular etiology [8].
We describe here a consanguineous Moroccan family
with three affected siblings (two boys and one girl)
showing typical signs of JBTS with hypotonia, mental re-
tardation, bilateral nystagmus, ataxia, retinitis pigment-
osa and a MTS on brain magnetic resonance imaging
(MRI). To identify the underlying genetic defect in this
family, we performed a genome-wide homozygosity
mapping using the high-resolution Affymetrix single




We describe a Moroccan family of three affected siblings
born to healthy consanguineous parents (parents are
first cousins; Fig. 1).
Patient 1, the first child, an 18-year-old boy, was re-
ferred to medical genetics for mental retardation and
visual impairment. Born at term, he had neonatal hypo-
tonia, and psychomotor delay, walked at 4 years of age
and had very poor language skills. He had visual impair-
ment, which was worse at night. He never attended
school. Urea and creatinine measured in his blood were
normal. On clinical examination, he had normal growth
parameters, bilateral horizontal nystagmus, and ataxia.
An ophthalmological examination showed retinitis pig-
mentosa. Brain MRI revealed a hypoplasia of his cerebel-
lar vermis with a MTS (Fig. 2).
Patient 2, a 13-year-old girl, had clinical findings simi-
lar to those of her older brother with psychomotor delay
and poor language skills. She walked at 2 years of age.
Patient 3, an 10-year-old boy, had clinical findings
similar to those of his older brother and sister. He also
had psychomotor delay and very poor language skills,
and walked at 3 years of age.
Molecular analysis
Homozygosity mapping performed using the high reso-
lution Affymetrix SNP 6.0 array revealed three homozy-
gous regions that were shared among affected siblings,
with a size of 1.7 Mb at 5q33.3, 30.1 Mb at 14q22–24 and
28.9 Mb at 6q22.1–24 respectively. Overall, the three in-
tervals contained more than 100 genes. We compared the
detected homozygous regions with known JBTS loci, and
found that the homozygous region on chromosome 6q
contained Abelson helper integration site 1 (AHI1), consid-
ered to be the gene at JBST3 locus. Direct sequencing of
the 26 coding exons revealed an insertion of an adenosine
base (c.910dup, p.Thr304AsnfsX6), located in exon 7
(NM_017651.4), causing a frameshift and predicting a pre-
mature protein truncation. The mutation was homozy-
gous in all patients (Fig. 3), heterozygous in their parents,
and not found in controls with the same ethnic back-
ground. Otherwise, the genomic array analysis detected
no pathological copy number variation (CNV) in particu-
lar at the nephronophthisis 1 (NPHP1) locus.
Discussion
The prevalence of JBTS ranges between 1:80,000 and
1:100,000 [9–11]. JBTS is genetically heterogeneous with
23 genes identified thus far. We used a whole-genome
approach to identify the homozygous loci in this family,
followed by a targeted Sanger sequencing of AHI1.
The homozygous p.Thr304AsnfsX6 mutation found in
this family was reported in one affected patient from a
consanguineous family originating from Spain [12] and
in two patients originating from the Netherlands [11]
(exon 7 for NM_017651.3). The spanish patient (family
MTI-107 in the article) had compound mutations re-
spectively in exon 8 (exon 7 in NM_017651.4) and in
exon 14. The p.Thr304AsnfsX6 mutation predicts a
prematurely truncated protein. Contrary to what was
Fig. 1 Pedigree of Moroccan family with Joubert syndrome. Patients 1, 2 and 3 were 18-, 13- and 10-years old respectively. Their parents are
first cousins
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Fig. 2 Magnetic Resonance Imaging (MRI): Sagittal and axial views through brainstem of patient 1 indicating hypoplasia of cerebellar vermis
(red stars a), horizontally oriented (red arrow, a) and elongated (black arrows, b) superior cerebellar peduncles forming the “molar tooth“
sign (headarrows, b and c)
Fig. 3 Sequence analysis. The three patients carry a homozygous mutation (p.Thr304AsnfsX6) causing frameshift and predicting a premature
protein truncation (a : affected daughter or patient 2, b : affected son or patient 1). Parents are heterozygous for the mutation (c, d)
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reported by Kroes et al. [11], this mutation is therefore
not specific for the Dutch population.
Most AHI1 mutations reported by Valente et al. [12]
and Kroes et al. [11] are truncating, except the two
V443D and R723Q missense mutations. Most mutations
cluster within exons 7 to 16. The occurrence of the
p.Thr304AsnfsX6 mutation in two unrelated families
(Moroccan and Spanish) may be due to a founder effect,
as reported for many other mutations in patients with
JBTS. The c.218 G>T mutation, resulting in p.Arg73Leu
in transmembrane protein 216 (TMEM216) has been
reported with a founder effect in the Ashkenazi Jewish
population [12]. As an Arab population (Moorish or
Moriscos) lived in Spain for hundreds years and many
converted to Christianity, the presence of the same mu-
tation in Arabic Moroccan and Spanish families with
JBTS suggests that they might share the same founder;
however, the two other patients from the Netherlands
with the same (p.Thr304AsnfsX6) mutation reported by
Kroes et al. [11] have a Dutch origin, as well as their
parents, as far as several generations back (personal
communication by Kroes). To investigate the genetic
history of this mutation in the Moroccan, Spanish, and
Dutch families with JBTS, the analysis of linkage disequi-
librium (LD) between flanking polymorphic markers and
AHI locus should shed light on the origin of this muta-
tion and estimate the age of the mutation, that is,
whether it was carried by a common ancestor or arose
due to a mutational hotspot.
Parisi et al. reported that 11 % of individuals with
JBTS had AHI1 mutations [10], Kroes et al. revealed
that 16 % of patients with JBTS from the Netherlands
had mutations in AHI1 [11], whereas Valente et al.
identified mutations in this gene in 7.3 % of individ-
uals in a cohort of patients with JSRDs [12]. Among
this large cohort of 137 families with JSRDs and a
demonstrated MTS, Valente et al. [12] identified 15
deleterious AHI1 mutations in 10 families with pure
JS or JS plus retinal and/or additional central nervous
system abnormalities. They reported that no correlate
was evident between the type of mutation (truncating,
missense, or splicing) or the exon involved and the
phenotypes observed [12]. They concluded that AHI1
mutations are a frequent cause of the disease in patients
with specific forms of JSRDs but are not responsible for
JSRDs with liver and kidney abnormalities. Valente et al.
[12] found that AHI1 mutations are a frequent cause of JS
with retinal involvement or other central nervous system
abnormalities, or both, which is consistent with our
report.
Almost 80 % of patients with AHI1 mutations have
retinal dystrophy [11, 13] and early onset congenital
blindness [12]. The three patients presented here and
the two patients reported by Froes et al. [11] carrying
the p.Thr304AsnfsX6 mutation showed retinal and
oculomotor abnormalities (that is, retinitis pigmentosa
or Leber congenital amaurosis, nystagmus). The ocu-
lar abnormalities were not observed in the Spanish
patient (MTI-107, 10-years old) reported by Valente
et al. [12].
Renal disease consistent with NPHP has also been
described in patients with JBTS with AHI1 mutations
[10, 11]. Renal ultrasound in our three patients did not re-
veal any abnormalities; renal disease was also absent in the
Spanish and Dutch patients with the same p.Thr304AsnfsX6
mutation. However, breathing abnormalities were absent in
our affected Moroccan siblings as compared to the Spanish
and Dutch patients. Other neurological malformations are
found to be variable among these patients with the same
mutation.
JSRDs is inherited predominantly in an autosomal
recessive manner. X-linked inheritance has been re-
ported in OFD1-related JSRDs. Digenic inheritance has
also been suggested. Lee et al. reported a digenism in
JBTS, resulting from a heterozygous CEP41 mutation in
combination with either a coiled-coil and C2 domain
containing 2A (CC2D2A) or a Kinesin family member 7
(KIF7) mutation [14]. Such digenic inheritance has also
been suggested in patients with AHI1 mutations and
NPHP1 deletions [11]. This observation suggests that
NPHP1 deletion leads to a large range of phenotypes
that can be modified by AHI1 mutations. The CNV ana-
lysis undertaken in our patients did not show any dele-
tion of the NPHP1 gene.
Our study demonstrates that homozygosity mapping is
a powerful method to rapidly detect the disease-causing
gene especially in clinically and genetically heteroge-
neous disorders such as JBTS.
Conclusions
In this study we detected a disease-causing mutation in
the AHI1 gene in a Moroccan family with JBTS by using
homozygosity mapping. The rare p.Thr304AsnfsX6 mu-
tation found in the Moroccan patients has been found in
one Spanish patient and in two patients from the
Netherlands in a heterozygous state suggesting that they
may share the same founder ancestor. This might be
more probable between Moroccan and Spanish families
because of a common history. The second hypothesis
proposes a mutational hotspot. In this study, the result
allows accurate genetic counselling and may offer a mo-
lecular prenatal diagnosis to this family.
Methods
Sampling and DNA extraction
The Moroccan family was recruited in the Genetics
Department of the National Institute of Health, Rabat,
Morocco. DNA was extracted from whole blood using
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the standard protocol for the three affected patients
and their parents. Written informed consent for gen-
etic analysis was obtained from the parents for them-
selves and for their children included in this study,
which conforms to the Helsinki Declaration and local
legislation.
Linkage analysis and homozygosity mapping
Affected individuals were selected for genome-wide SNP
analysis using the high-resolution Affymetrix SNP 6.0
array containing 906,600 polymorphic SNPs and more
than 946,000 unique probes for CNV detection. The
genotyping of patients and parents was performed ac-
cording to the manufacturer’s protocol. The regions of
homozygosity (ROHs) were detected by the Affymetrix®
Chromosome Analysis Suite (ChAS) software.
Mutation analysis
Exons and intron–exon boundaries of AHI1 were se-
quenced in one proband using 3130 Automated Sequen-
cer (Applied Biosystems, Foster City, CA, USA). We used
a touchdown protocol for the polymerase chain reaction
(PCR) procedures to amplify all exons in the same condi-
tions. Primer sequences and PCR conditions are available
on request.
Consent
Written informed consent was obtained from the family
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this Journal.
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